RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Hackensack, NJ · +43 more sites
Prostate Cancer clinical trials in Hackensack, NJ
13 recruiting prostate cancer studies with a site in Hackensack, NJ.
RecruitingPhase 1 / Phase 2NCT07529717
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Sponsor: AstraZeneca
East Brunswick, NJ · Hackensack, NJ · +2 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Hackensack, NJ · Teaneck, NJ · +332 more sites
RecruitingPhase 2NCT06632977
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Sponsor: Alliance for Clinical Trials in Oncology
Hackensack, NJ · +107 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
East Brunswick, NJ · Hackensack, NJ · +44 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
East Brunswick, NJ · Hackensack, NJ · New Brunswick, NJ · +21 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Hackensack, NJ · +21 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Camden, NJ · Hackensack, NJ · New Brunswick, NJ · +338 more sites
RecruitingPhase 2NCT06798558
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Sponsor: Hackensack Meridian Health
Hackensack, NJ · +2 more sites
RecruitingNot applicableNCT07011342
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
Sponsor: Hackensack Meridian Health
Hackensack, NJ
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Hackensack, NJ · +12 more sites
RecruitingPhase 1NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Sponsor: Clasp Therapeutics, Inc.
Hackensack, NJ · +20 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Hackensack, NJ · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.